6-[
18F] Fluorine-3,4-dihydroxyphenyl-L-alanine (
18F-Dopa)
was used for the diagnosis of malfunction
of the D
2 dopaminergic presynaptic system with
positron emission tomography (PET). However
18F-Dopa has multiple metabolic pathways: for
example, it is metabolized to 3-O-methyl-6-
18F-4-
hydroxyphenylalanine, which deteriorate the images
of
18F-dopamine. In order to eliminate such contaminations,
L-
18F-meta-tyrosine (L-
18FmT) was
synthesized and used to obtain clear images of high
uptake of L-
18FmT on the striatum of four
normal monkeys.
Two models of Parkinson's disease were generated
by injection of 1-methy-4-phenyl-1,2,3,6-tetra
hydropyridine in the monkey. Dynamic and static
images were obtained after intravenous injection of
185 MBq of L-
18FmT, using a high-resolution animal
PET system SHR-2000. In the normal monkey,
there was a symmetrical uptake of L-
18FmT specifically
on the striatum with a striatum-to-occipital
lobe uptake ratio of about 4.0 at 110 min after
injection. On the other hand, in the Parkinson
model there was no uptake on the diseased side of
the striatum. These results indicate that L-
18FmT is
a good radiotracer for imaging of D
2 dopaminergic
presynaptic function.
View full abstract